The latest developments from
Quest Diagnostics (DGX) indicate a dynamic and strategic outlook for the company. A number of announcements reveal that the company is profoundly invested in the expansion and improvement of its services. Aspects such as
increase in digital pathology, a new deal with PathAI to expedite the adoption of
AI and Digital Pathology in
cancer diagnosis bolsters this claim. Additionally, the appointment of
Murali Balakumar as the Senior Vice President and Chief Information and Digital Officer suggests reinforced focus on digital strategy. The company’s stakes are growing. Natixis Advisors L.P. have increased their holdings in DGX, as have the Retirement Systems of Alabama and Swiss National bank. Quest Diagnostics has reported
growth in base volume and appears to have a
positive momentum. The company
exceeded Q1 earnings and revenue estimates, and has subsequently raised their
guidance for full year 2024. DGX has also formed collaborations with Broad Clinical Labs and Instacart to augment its service offerings. All these point to a proactive and progressive company operating model.
Quest Diagnostics DGX News Analytics from Wed, 30 Aug 2023 07:00:00 GMT to Wed, 08 May 2024 16:36:02 GMT -
Rating 9
- Innovation 8
- Rumor 6
